Background:
The modern society is extremely prone to many life-threatening diseases, which can be easily controlled as well as cured if diagnosed at an early stage. The development and implementation of a disease diagnostic system have gained huge popularity over the years. In the current scenario, there are certain factors such as environment, sedentary lifestyle, genetic (hereditary) are the major factors behind the life threatening disease such as, ‘diabetes’. Moreover, diabetes has achieved the status of the modern man’s leading chronic disease. So one of the prime need of this generation is to develop a state-of-the-art expert system which can predict diabetes at a very early stage with a minimum of complexity and in an expedited manner. The primary objective of this research work is to develop an indigenous and efficient diagnostic technique for detection of the diabetes.
Method & Discussion:
The proposed methodology comprises of two phases: In the first phase The Pima Indian Diabetes Dataset (PIDD) has been collected from the UCI machine learning repository databases and Localized Diabetes Dataset (LDD) has been gathered from Bombay Medical Hall, Upper Bazar Ranchi, Jharkhand, India. In the second phase, the dataset has been processed through two different approaches. The first approach entails classification through Adaboost, Classification Via Regression (CVR), Radial Basis Function Network (RBFN), K-Nearest Neighbor (KNN) on Pima Indian Diabetes Dataset and Localized Diabetes Dataset. In the second approach, Principal Component Analysis (PCA) and Linear Discriminant Analysis (LDA) have been applied as a feature reduction method followed by using the same set of classification methods used in the first approach. Among all of the implemented classification method, PCA_CVR performs the highest performance for both the above mentioned dataset.
Conclusion:
In this research article, comparative analysis of outcomes obtained by with and without the use of PCA and LDA for the same set of classification method has been done w.r.t performance assessment. Finally, it has been concluded that PCA & LDA both is useful to remove the insignificant features, decreasing the expense and computation time while improving the ROC and accuracy. The used methodology may similarly be applied in other medical diseases.
The order of amino acids in a protein sequence enables the protein to acquire a conformation suitable for performing functions, thereby motivating the need to analyse these sequences for predicting functions. Although machine learning based approaches are fast compared to methods using BLAST, FASTA, etc., they fail to perform well for long protein sequences (with more than 300 amino acids). In this paper, we introduce a novel method for construction of two separate feature sets for protein using bi-directional long short-term memory network based on the analysis of fixed 1) single-sized segments and 2) multi-sized segments. The model trained on the proposed feature set based on multi-sized segments is combined with the model trained using state-of-the-art Multi-label Linear Discriminant Analysis (MLDA) features to further improve the accuracy. Extensive evaluations using separate datasets for biological processes and molecular functions demonstrate not only improved results for long sequences, but also significantly improve the overall accuracy over state-of-the-art method. The single-sized approach produces an improvement of +3.37% for biological processes and +5.48% for molecular functions over the MLDA based classifier. The corresponding numbers for multi-sized approach are +5.38% and +8.00%. Combining the two models, the accuracy further improves to +7.41% and +9.21% respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.